Desjardins Issues Pessimistic Forecast for Kits Eyecare (TSE:KITS) Stock Price

Key Points

• Analyst cuts: Desjardins lowered its price target on Kits Eyecare from C$25.00 to C$23.00 while retaining a "buy" rating (implying ~101% upside), and ATB Cormark trimmed its target to C$16.75 with a "speculative buy"; the consensus rating remains "Buy" with an average target of C$20.69.
• Share decline and valuation: Shares fell 7.7% to C$11.43 on heavy volume (306,356 vs. average 115,911), valuing the company at C$388.5M with a P/E of 127.0 and a 1‑year range of C$11.12–C$22.56.
• Recent results: Kits reported quarterly EPS of C$0.06 and revenue of C$57.47 million on May 6.

Kits Eyecare (TSE:KITS - Get Free Report) had its price objective lowered by equities research analysts at Desjardins from C$25.00 to C$23.00 in a note issued to investors on Thursday,BayStreet.CA reports. The brokerage presently has a "buy" rating on the stock. Desjardins' target price would indicate a potential upside of 101.22% from the stock's previous close.

Separately, ATB Cormark Capital Markets reduced their price target on shares of Kits Eyecare from C$20.00 to C$16.75 and set a "speculative buy" rating for the company in a report on Thursday. Four equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of C$20.69.

Kits Eyecare Trading Down 7.7%

Shares of Kits Eyecare stock traded down C$0.95 on Thursday, reaching C$11.43. 306,356 shares of the company were exchanged, compared to its average volume of 115,911. The stock has a market capitalization of C$388.51 million, a price-to-earnings ratio of 127.00 and a beta of 0.46. Kits Eyecare has a 1-year low of C$11.12 and a 1-year high of C$22.56.

Kits Eyecare (TSE:KITS - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$57.47 million for the quarter.

Kits Eyecare Company Profile

KITS TSX: KITS is one of the world's fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.